BIVICTRIX Trademark

Trademark Overview


On Tuesday, February 22, 2022, a trademark application was filed for BIVICTRIX with the United States Patent and Trademark Office. The USPTO has given the BIVICTRIX trademark a serial number of 79345166. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Monday, September 30, 2024. This trademark is owned by BIVICTRIX LIMITED. The BIVICTRIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, preparations for the treatment of cancer; medical preparations, namely, preparations for the treatment of cancer; veterinary preparations, namely, preparations for the treatment of cancer; anti-cancer drugs; anti-cancer preparations of chemical origin; anti-cancer preparations of plant origin; biological preparations for medical purposes, namely, for the treatment of cancer; biological preparations for the treatment of cancer; biopharmaceutical preparations for the treatment of cancer; biotechnological preparations for medical use for the treatment of cancer; chemical preparations for medical purposes, namely, for prevention or treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for prevention or treatment of cancer; chemical preparations for pharmaceutical use, namely, for prevention or treatment of cancer; chemotherapeutics; pharmaceutical compounds for treating cancer; drugs for medical purposes for the treatment of ca...
bivictrix

General Information


Serial Number79345166
Word MarkBIVICTRIX
Filing DateTuesday, February 22, 2022
Status645 - FINAL REFUSAL - MAILED
Status DateMonday, September 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, preparations for the treatment of cancer; medical preparations, namely, preparations for the treatment of cancer; veterinary preparations, namely, preparations for the treatment of cancer; anti-cancer drugs; anti-cancer preparations of chemical origin; anti-cancer preparations of plant origin; biological preparations for medical purposes, namely, for the treatment of cancer; biological preparations for the treatment of cancer; biopharmaceutical preparations for the treatment of cancer; biotechnological preparations for medical use for the treatment of cancer; chemical preparations for medical purposes, namely, for prevention or treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for prevention or treatment of cancer; chemical preparations for pharmaceutical use, namely, for prevention or treatment of cancer; chemotherapeutics; pharmaceutical compounds for treating cancer; drugs for medical purposes for the treatment of cancer; medicines, namely, medicines for cancer disorders; medicines for human purposes, namely, cancer medicines; pharmaceutical compositions, namely, preparations for the treatment of cancer; pharmaceutical drugs, namely, preparations for the treatment of cancer; pharmaceutical preparations, namely, preparations for the treatment of cancer; pharmaceutical preparations and substances, namely, preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for human use, namely, preparations for the treatment of cancer; pharmaceutical preparations for medical purposes, namely, preparations for the treatment of cancer; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the treatment of cancer; pharmaceutical products for the treatment of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 15, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBIVICTRIX LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, July 14, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, July 15, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 19, 2022APPLICATION FILING RECEIPT MAILED
Tuesday, December 6, 2022ASSIGNED TO EXAMINER
Monday, December 19, 2022NON-FINAL ACTION WRITTEN
Tuesday, December 20, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, February 15, 2023REFUSAL PROCESSED BY MPU
Wednesday, February 15, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, March 6, 2023REFUSAL PROCESSED BY IB
Tuesday, August 15, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 15, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 2, 2023LETTER OF SUSPENSION E-MAILED
Monday, October 2, 2023SUSPENSION LETTER WRITTEN
Monday, October 2, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, December 20, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 20, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sunday, January 7, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, April 2, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, September 30, 2024FINAL REFUSAL WRITTEN
Monday, September 30, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, September 30, 2024FINAL REFUSAL E-MAILED
Friday, March 28, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 28, 2025TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, March 28, 2025TEAS/EMAIL CORRESPONDENCE ENTERED